Effect of Periodic Letters on Evidence-Based Drug Therapy on Prescribing Behaviour: A Randomized Trial
Author: Dormuth C, Maclure M, Bassett K, Jauca C, Whiteside C, Wright J
Intervention Type: Distribution of Educational Materials to Professionals
Disease State: Not specific to any chronic disease
Research Objective
To measure the impact on prescribing behaviour of a series of evidence-based drug therapy letters mailed to physicians in British Columbia on prescribing to newly treated patients
Methods
Design: Cluster randomized controlled trial (by physician) that was 38 months in duration
Study sample: General practitioners; newly-treated community-dwelling adults (66+ years, except for asthma letter where sample was 60+ years)
Intervention:
Group 1 – Intervention: Series of twelve issues of an evidence-based series called, Therapeutics Letter, mailed by the UBC Therapeutics Initiative group addressing a variety of different drug reviews or disease management topics in primary care. Half of the letters were predicted to show an increase in prescriptions to newly treated patients, and half were predicted to show a decrease. Effects of each letter on prescribing were measured by counting the number of newly treated patients who received that letter’s analysis drug before versus after the intervention.
Group 2 – Control: Usual care
Medication Prescribing and Use Outcomes
Key Results
Key Implementation Issues
Citation(s)
Effect of Periodic Letters on Evidence-Based Drug Therapy on Prescribing Behaviour: A Randomized Trial. Dormuth, C.R.., Maclure, M., Bassett, K., Jauca, C., Whiteside, C., & Wright, J.M.. Canadian Medical Association Journal (2004), 171(9), 1057-1061